REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 63 filers reported holding REPARE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $618,919 | +6.7% | 51,235 | -6.6% | 0.00% | – |
| Q2 2023 | $580,228 | +7.7% | 54,842 | +0.1% | 0.00% | – |
| Q1 2023 | $538,857 | +68719.5% | 54,762 | +3.0% | 0.00% | – |
| Q4 2022 | $783 | -99.5% | 53,185 | +309.8% | 0.00% | – |
| Q3 2022 | $157,000 | -73.2% | 12,979 | -69.0% | 0.00% | – |
| Q2 2022 | $585,000 | -17.5% | 41,846 | -16.0% | 0.00% | – |
| Q1 2022 | $709,000 | -34.7% | 49,811 | -3.2% | 0.00% | – |
| Q4 2021 | $1,085,000 | +5.3% | 51,436 | +31.1% | 0.00% | – |
| Q3 2021 | $1,030,000 | – | 39,241 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,242,636 | $22,067,538 | 9.20% |
| CHI Advisors LLC | 2,997,939 | $29,499,719 | 7.83% |
| MPM BioImpact LLC | 1,639,849 | $16,136,114 | 4.19% |
| BVF INC/IL | 8,291,988 | $81,593,162 | 2.98% |
| HighVista Strategies LLC | 164,890 | $1,622,518 | 1.32% |
| Sio Capital Management, LLC | 228,538 | $2,248,814 | 1.11% |
| Deep Track Capital, LP | 2,727,606 | $26,839,643 | 1.10% |
| Redmile Group, LLC | 2,533,050 | $24,925,212 | 1.08% |
| Orbimed Advisors | 3,322,488 | $32,693,282 | 0.64% |
| Artal Group S.A. | 700,000 | $6,888 | 0.41% |